Towa Pharmaceutical Co., Ltd.
TWAPF
Updated: 23/09/2026, 23:28:06
Operating in Japan, Towa Pharmaceutical Co., Ltd. and its subsidiaries are engaged in the research, development, production, and sale of prescription drugs, active pharmaceutical ingredients, and intermediates. The company's extensive portfolio addresses critical therapeutic areas such as diabetes, digestive health, neurological conditions, and allergic diseases, alongside offering vitamins, antibiotics, and oncology treatments. With approximately 700 different drug products, Towa Pharmaceutical Co., Ltd. was established in 1951 and is headquartered in Osaka, Japan.
No summaries found.
- Share price
- $25.98
- Market cap
- $1.28B
- Exchange
- OTC
- Currency
- USD
- CEO
- Itsuro Yoshida
- Employees
- 4,923
- IPO date
- 21/10/2009
- Beta
- -0.08599999999999999
- Last dividend
- $0.00
- Day range
- $25.98 – $26.00
- 52-week range
- $16.83 – $26.00
- 1-day performance
- 0.00%
- 1-year performance
- 54.37%
- Current drawdown (1Y)
- -0.08%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- JP3623150004
- Created
- 07/12/2025, 14:49:55
- Last update
- 23/09/2026, 23:28:06
Track Towa Pharmaceutical Co., Ltd. with an AI analyst
See which prediction-market events move TWAPF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.